Evaluating the performance of a clinical genome sequencing program for diagnosis of rare genetic disease, seen through the lens of craniosynostosis

Abstract

Purpose Genome sequencing (GS) for diagnosis of rare genetic disease is being introduced into the clinic, but the complexity of the data poses challenges for developing pipelines with high diagnostic sensitivity. We evaluated the performance of the Genomics England 100,000 Genomes Project (100kGP) panel-based pipelines, using craniosynostosis as a test disease. Methods GS data from 114 probands with craniosynostosis and their relatives (314 samples), negative on routine genetic testing, were scrutinized by a specialized research team, and diagnoses compared with those made by 100kGP. Results Sixteen likely pathogenic/pathogenic variants were identified by 100kGP. Eighteen additional likely pathogenic/pathogenic variants were identified by the research team, indicating that for craniosynostosis, 100kGP panels had a diagnostic sensitivity of only 47%. Measures that could have augmented diagnoses were improved calling of existing panel genes (+18% sensitivity), review of updated panels (+12%), comprehensive analysis of de novo small variants (+29%), and copy-number/structural variants (+9%). Recent NHS England recommendations that partially incorporate these measures should achieve 85% overall sensitivity (+38%). Conclusion GS identified likely pathogenic/pathogenic variants in 29.8% of previously undiagnosed patients with craniosynostosis. This demonstrates the value of research analysis and the importance of continually improving algorithms to maximize the potential of clinical GS.

A systematic analysis of splicing variants identifies new diagnoses in the 100,000 Genomes Project

“…Clearly, many new diagnoses remain to be found. A recent analysis of 100KGP data in the context of craniosynostosis found that expert-led review more than doubled diagnostic yields compared to the standard pipeline 3 . An important factor is that the “virtual panels “ applied to variant calls are outdated and do not include recently discovered disease genes.…”

“…Diagnostic yields in individuals with rare diseases remain below 50%, despite extensive investigations including whole-genome sequencing 2 . The accurate interpretation of genomic variants in existing sequencing data presents an important opportunity to narrow the diagnostic gap 3 . Splicing is the process by which introns are removed from a pre-mRNA primary transcript.…”

An additional whole-exome sequencing study in 102 panel-undiagnosed patients: A retrospective study in a Chinese craniosynostosis cohort

“…Clinical interpretation of genomic variants requires the standard classification guidelines and workflows, as well as considering the consistency between a variant and a disease phenotype by enough solid evidence. Research-based analysis performed by the Clinical Genetics Group, Oxford (CGG) identified additionally over one-fold P/LP variants than the GE/GMC pipeline for rare diseases, which demonstrated the value of research analysis and the importance of continually improving algorithms to maximize the potential of clinical genome sequencing (Hyder et al, 2021). Our study combined the CMM pipeline following the ACMG guideline and the RP as a supplement.…”

Navigating an early career in genomics and data science, written from the perspective of a current PhD student

“…Although I do not use AI or machine learning in my research, I regularly use bioinformatics approaches in my analysis of sequencing data and variant prioritization, examples of which can be found in our recent paper, published in Genetics in Medicine . 1 …”

“…Although I do not use AI or machine learning in my research, I regularly use bioinformatics approaches in my analysis of sequencing data and variant prioritization, examples of which can be found in our recent paper, published in Genetics in Medicine. 1 Which of the current trends in data science seem the most interesting to you? In your opinion, what are the most pressing questions for the data science community?…”